Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | RCUS |
---|---|---|
09:32 ET | 9921 | 13.88 |
09:34 ET | 18800 | 13.81 |
09:36 ET | 7708 | 13.81 |
09:38 ET | 3135 | 13.6164 |
09:39 ET | 14023 | 13.8 |
09:41 ET | 7761 | 13.94 |
09:43 ET | 1100 | 13.915 |
09:45 ET | 1882 | 14.01 |
09:48 ET | 5700 | 13.985 |
09:50 ET | 5200 | 13.98 |
09:52 ET | 1250 | 14.0199 |
09:54 ET | 3796 | 13.94 |
09:56 ET | 10587 | 13.85 |
09:57 ET | 1542 | 13.785 |
09:59 ET | 11044 | 13.805 |
10:01 ET | 2237 | 13.83 |
10:03 ET | 24442 | 13.6301 |
10:06 ET | 600 | 13.64 |
10:08 ET | 13353 | 13.675 |
10:10 ET | 3243 | 13.675 |
10:12 ET | 2240 | 13.75 |
10:14 ET | 800 | 13.75 |
10:15 ET | 5830 | 13.82 |
10:17 ET | 600 | 13.855 |
10:19 ET | 34913 | 13.78 |
10:21 ET | 509 | 13.77 |
10:24 ET | 3000 | 13.77 |
10:26 ET | 1915 | 13.82 |
10:28 ET | 400 | 13.835 |
10:30 ET | 400 | 13.845 |
10:32 ET | 5161 | 13.85 |
10:33 ET | 1426 | 13.86 |
10:35 ET | 619 | 13.861 |
10:37 ET | 2433 | 13.85 |
10:39 ET | 950 | 13.88 |
10:42 ET | 300 | 13.885 |
10:44 ET | 2576 | 14.03 |
10:46 ET | 400 | 14.03 |
10:48 ET | 922 | 14.085 |
10:50 ET | 600 | 14.125 |
10:51 ET | 500 | 14.115 |
10:53 ET | 455 | 14.15 |
10:55 ET | 400 | 14.12 |
10:57 ET | 300 | 14.145 |
11:00 ET | 718 | 14.06 |
11:02 ET | 581 | 14.07 |
11:04 ET | 101 | 14.03 |
11:09 ET | 442 | 14.08 |
11:13 ET | 300 | 14.07 |
11:15 ET | 600 | 14.065 |
11:18 ET | 653 | 14.09 |
11:20 ET | 1100 | 14.06 |
11:22 ET | 400 | 14.09 |
11:24 ET | 901 | 14.06 |
11:26 ET | 600 | 14.03 |
11:31 ET | 794 | 14.01 |
11:40 ET | 100 | 14.05 |
11:42 ET | 760 | 14.05 |
11:44 ET | 4205 | 14.16 |
11:45 ET | 2164 | 14.23 |
11:47 ET | 3253 | 14.26 |
11:49 ET | 200 | 14.32 |
11:51 ET | 810 | 14.34 |
11:54 ET | 300 | 14.3 |
11:56 ET | 800 | 14.32 |
11:58 ET | 1400 | 14.23 |
12:00 ET | 5600 | 14.21 |
12:02 ET | 400 | 14.21 |
12:03 ET | 200 | 14.2 |
12:05 ET | 100 | 14.16 |
12:07 ET | 100 | 14.16 |
12:09 ET | 100 | 14.18 |
12:12 ET | 1611 | 14.16 |
12:14 ET | 100 | 14.11 |
12:16 ET | 1091 | 14.06 |
12:18 ET | 816 | 14.085 |
12:20 ET | 710 | 14.12 |
12:21 ET | 500 | 14.1 |
12:23 ET | 100 | 14.07 |
12:25 ET | 300 | 14.115 |
12:27 ET | 100 | 14.09 |
12:30 ET | 315 | 14.11 |
12:32 ET | 334 | 14.1 |
12:34 ET | 522 | 14.09 |
12:36 ET | 300 | 14.09 |
12:38 ET | 200 | 14.07 |
12:39 ET | 312 | 14.07 |
12:43 ET | 1000 | 14.04 |
12:45 ET | 2794 | 14.04 |
12:48 ET | 200 | 14.03 |
12:50 ET | 1424 | 14.05 |
12:54 ET | 1325 | 14.12 |
12:56 ET | 200 | 14.11 |
12:57 ET | 475 | 14.105 |
01:01 ET | 100 | 14.1 |
01:03 ET | 100 | 14.09 |
01:06 ET | 549 | 14.09 |
01:10 ET | 300 | 14.08 |
01:12 ET | 906 | 14.04 |
01:14 ET | 1762 | 14.04 |
01:15 ET | 100 | 14.06 |
01:17 ET | 300 | 14.05 |
01:19 ET | 206 | 14.06 |
01:21 ET | 200 | 14.04 |
01:24 ET | 200 | 14.07 |
01:26 ET | 376 | 14.07 |
01:28 ET | 100 | 14.06 |
01:30 ET | 1226 | 14.09 |
01:32 ET | 1280 | 14.07 |
01:33 ET | 859 | 14.07 |
01:35 ET | 100 | 14.06 |
01:37 ET | 400 | 14.1 |
01:39 ET | 500 | 14.11 |
01:42 ET | 200 | 14.09 |
01:44 ET | 17200 | 14.165 |
01:48 ET | 6218 | 14.07 |
01:50 ET | 9625 | 14.11 |
01:53 ET | 200 | 14.07 |
01:55 ET | 1202 | 14.09 |
01:57 ET | 406 | 14.13 |
02:00 ET | 1201 | 14.15 |
02:02 ET | 400 | 14.14 |
02:04 ET | 200 | 14.13 |
02:06 ET | 100 | 14.14 |
02:08 ET | 600 | 14.1 |
02:09 ET | 800 | 14.12 |
02:11 ET | 100 | 14.12 |
02:15 ET | 6758 | 14.06 |
02:18 ET | 400 | 14.06 |
02:20 ET | 300 | 14.06 |
02:22 ET | 200 | 14.07 |
02:24 ET | 902 | 14.06 |
02:26 ET | 7266 | 14.095 |
02:27 ET | 450 | 14.08 |
02:31 ET | 1812 | 14.075 |
02:33 ET | 100 | 14.07 |
02:36 ET | 730 | 14.065 |
02:38 ET | 100 | 14.06 |
02:40 ET | 1454 | 14.04 |
02:42 ET | 100 | 14.01 |
02:44 ET | 2012 | 14.05 |
02:45 ET | 300 | 14.05 |
02:47 ET | 901 | 14.04 |
02:49 ET | 1299 | 14.04 |
02:54 ET | 789 | 14.02 |
02:58 ET | 595 | 14.03 |
03:00 ET | 1654 | 14.05 |
03:02 ET | 2118 | 14.06 |
03:03 ET | 1585 | 14.04 |
03:05 ET | 100 | 14.02 |
03:07 ET | 896 | 14.045 |
03:09 ET | 2020 | 14.1 |
03:12 ET | 1271 | 14.065 |
03:14 ET | 710 | 14.06 |
03:16 ET | 357 | 14.06 |
03:18 ET | 370 | 14.05 |
03:20 ET | 200 | 14.05 |
03:21 ET | 300 | 14.055 |
03:23 ET | 100 | 14.05 |
03:25 ET | 1906 | 14.06 |
03:27 ET | 401 | 14.05 |
03:30 ET | 834 | 14.04 |
03:32 ET | 3947 | 14.015 |
03:34 ET | 302 | 14 |
03:36 ET | 1183 | 13.99 |
03:38 ET | 300 | 13.99 |
03:39 ET | 1858 | 13.99 |
03:41 ET | 1870 | 13.99 |
03:43 ET | 100 | 14 |
03:45 ET | 1332 | 13.99 |
03:48 ET | 3323 | 13.98 |
03:50 ET | 4553 | 14.01 |
03:52 ET | 4300 | 14.045 |
03:54 ET | 12011 | 13.995 |
03:56 ET | 46051 | 14.1 |
03:57 ET | 12636 | 14.065 |
03:59 ET | 63930 | 14.12 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Arcus Biosciences Inc | 1.3B | -4.6x | --- |
Ardelyx Inc | 1.2B | -18.4x | --- |
Vir Biotechnology Inc | 1.2B | -2.1x | --- |
Gyre Therapeutics Inc | 1.0B | -6.6x | --- |
Immatics NV | 1.2B | -11.1x | --- |
Prothena Corporation PLC | 1.1B | -6.2x | --- |
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing differentiated molecules and combination therapies for people with cancer. The Company involves in a portfolio of investigational products, which are in clinical development with its advanced molecule, an anti-TIGIT antibody targeting lung and gastrointestinal cancers. The Company has approximately seven clinical programs that are focused on targets, including TIGIT, PD-1, adenosine A2a and A2b receptors, CD73, CD39, HIF-2a, and AXL. The Company is engaged in co-developing four investigational products, including zimberelimab (Arcuss anti-PD-1 molecule), domvanalimab (Arcuss anti-TIGIT antibody), etrumadenant (Arcuss adenosine receptor antagonist) and quemliclustat (Arcuss CD73 inhibitor). It is engaged in pursuing a Phase II and Phase III development program for domvanalimab in combination with its anti-PD-1 antibody, zimberelimab, in multiple settings, including lung and gastrointestinal cancer.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.3B |
---|---|
Revenue (TTM) | $237.0M |
Shares Outstanding | 91.0M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.89 |
EPS | $-3.10 |
Book Value | $6.12 |
P/E Ratio | -4.6x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -113.92% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.